MADRYN ASSET MANAGEMENT, LP 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-30 5:38 pm Purchase |
2020-11-30 | 13G | Aquestive Therapeutics, Inc. AQST |
MADRYN ASSET MANAGEMENT, LP | 1,530,717 4.200% |
102,145 (+7.15%) |
Filing |